A Collection of Pharma Sources Insight 2020, Open to Review on the Pharma Industry 2020

Pharma Sources Insight is a selection of hot articles written by the most popular expert writers on PharmaSources.com. 

From June to October, Pharma Sources Insights have been focused on the topics of new developments on COVID-19 Treatments, What's up with the China Pharmaceutical Companies and Global Industrial Trends, covering R&D, Approval to Sales Performance of the drugs.

Now, let's have a review on the three issues of Pharma Sources Insight in 2020, stay tuned with Pharmasources.com for the updated news on the pharmaceutical industry and more to come!

Pharma Sources Insight October 2020 focuses on the following topics:

PHARMA IN CHINA

- Trends in China’s Pharmaceutical Industry in 2020

- Chinese API active pharmaceutical ingredient and Their Role in the World’s Pharmaceutical Industry

- Chinese Pharma Firms Can Support Africa Reduce Import Bill

- Insights into the Oncology Landscape in China

- The Impact of the Human Genome Project on China Pharmaceutical Industry 20 Years Later

- A Comparison of Top Ten Best-Selling Oncology Drugs in China and the U.S. in 2019

- Which Will Go Further? Innovent or Junshi?

- Production Applications of Chinese New Drugs in 2020 H1: Five Class 1 New Chemical Drugs, Two Anti-PD-1 Monoclonal Antibodies and Two CAR T-Cell Products Applied for Production for the First Time

Brand Story

- PIONEER SPEED - Charming Fully Support All the Pharmaceutical Companies to Fight Against COVID-19

- Hiray Pharmaceutical, Innovating for Life

- An Opportunity for Pharmaceuticals Logistics During the Special Period : Cold Chain Railway Transport

Industry Insight

"A Smarter Pharma Industry: The Key to Addressing Challenges During the COVID-19 Pandemic"

Click on the link or Scan the QR code to read the Pharma Sources Insight (October 2020):

Pharma Sources Insight August 2020 focuses on the following topics:

COVID-19

-Developments of COVID-19 diagnostic test

-Will the Bottles be Enough with the Marketing of COVID-19 Vaccine?

-Designing the Messenger: Story of the mRNA Vaccine

-Inactivated Virus Vaccines vs. mRNA Vaccines: Differences between China and the U.S. in Preferred Technologies for Developing COVID-19 Vaccines

Global News

-With Up to 18 First Generics, Hansoh Ranking Second in the Industry in China

-A Review of the Great Journey of Capecitabine that Has Been Marketed in China for 20 Years

-The Layout of Inhalation Formulations in the Chinese Market (I)

-The Layout of Inhalation Formulations in the Chinese Market (II)

Brand Story

-Oriented by Product Innovation, Dongtai Pharma Striving to Build a Global Characteristic Pharmaceutical Brand

-"Interview Changzhou Golden Bright Pharmaceutical Factory: How to achieve safe production while ensuring quality?"

Industry Insight

- Advantages to Using CROs

Click on the link or Scan the QR code to read the Pharma Sources Insight (August 2020):

Pharma Sources Insight June 2020

Pharma Sources Insight June 2020 focuses on the following topics:

COVID-19

-A Post-pandemic Future

-How will the Epidemic’s Identification as a PHEIC Affect China’s API Export?

-A Review of the Three Chinese Patent Medicines Affirmed by the National Administration of TCM of China to Treat COVID-19

-A Quick Look at the Anti-epidemic Monoclonal Antibodies that Target the Novel Coronavirus S Protein

-Cell and Gene Therapies: Keep Calm and Carry On

-FDA Fast Track for New Vaccine During COVID-19 Pandemic

-Global Efforts Towards Coronavirus Vaccines：Can We Beat It?

Global News

-Technical Exploration of the Blue Ocean: Algal Polysaccharides

-NASH: Seizing Opportunities in the Untapped Market

-The Second ADC Approved for Marketing in China

-Chiatai Tianqing's High-difficulty Generic Drug "Fulvestrant Injection" Approved in the US: Sales of the Original Drug was $1.028 Billion in 2018

-Top 50 Drugs by Sales to Sample Hospitals in China in 2019

-A Comparison of the Biosimilar Accessibility of China, the EU, and the U.S.: China’s Biosimilars Commercialized at an Impressive Speed

Industry Insight

- Old Drugs for New Indications

Click on the link or Scan the QR code to read the Pharma Sources Insight (June 2020):

About Pharma Sources Insight

Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with those among the leading drug-manufacturers in China which further affect the world.

Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.